These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37829758)

  • 1. Editorial: Molecular pathology in psychiatric diseases: frontiers of postmortem brain research.
    Kunii Y; Hino M; Tomita H
    Front Psychiatry; 2023; 14():1286182. PubMed ID: 37829758
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmortem brain tissue as an underutilized resource to study the molecular pathology of neuropsychiatric disorders across different ethnic populations.
    Vornholt E; Luo D; Qiu W; McMichael GO; Liu Y; Gillespie N; Ma C; Vladimirov VI
    Neurosci Biobehav Rev; 2019 Jul; 102():195-207. PubMed ID: 31028758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid composition of the postmortem corpus callosum of patients with schizophrenia, bipolar disorder, or major depressive disorder.
    Hamazaki K; Maekawa M; Toyota T; Dean B; Hamazaki T; Yoshikawa T
    Eur Psychiatry; 2017 Jan; 39():51-56. PubMed ID: 27821355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Inflammatory Marker Abnormalities in Major Psychiatric Diseases: a Systematic Review of Postmortem Brain Studies.
    Ai YW; Du Y; Chen L; Liu SH; Liu QS; Cheng Y
    Mol Neurobiol; 2023 Apr; 60(4):2116-2134. PubMed ID: 36600081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder.
    Hamazaki K; Hamazaki T; Inadera H
    Psychiatry Res; 2013 Nov; 210(1):346-50. PubMed ID: 23731984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic variation of RELN expression in schizophrenia and bipolar disorder.
    Ovadia G; Shifman S
    PLoS One; 2011; 6(5):e19955. PubMed ID: 21603580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmortem human brain genomics in neuropsychiatric disorders--how far can we go?
    Jaffe AE
    Curr Opin Neurobiol; 2016 Feb; 36():107-11. PubMed ID: 26685806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium.
    Johnston-Wilson NL; Sims CD; Hofmann JP; Anderson L; Shore AD; Torrey EF; Yolken RH
    Mol Psychiatry; 2000 Mar; 5(2):142-9. PubMed ID: 10822341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.
    Torrey EF; Barci BM; Webster MJ; Bartko JJ; Meador-Woodruff JH; Knable MB
    Biol Psychiatry; 2005 Feb; 57(3):252-60. PubMed ID: 15691526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder.
    Hamazaki K; Maekawa M; Toyota T; Dean B; Hamazaki T; Yoshikawa T
    Psychiatry Res; 2015 Jun; 227(2-3):353-9. PubMed ID: 25858798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of psychiatric diagnosis in postmortem research.
    Deep-Soboslay A; Akil M; Martin CE; Bigelow LB; Herman MM; Hyde TM; Kleinman JE
    Biol Psychiatry; 2005 Jan; 57(1):96-101. PubMed ID: 15607306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes in Neuropsychiatric Disorders: A Review of Postmortem Evidence.
    Zhang X; Alnafisah RS; Hamoud AA; Shukla R; McCullumsmith RE; O'Donovan SM
    Adv Neurobiol; 2021; 26():153-172. PubMed ID: 34888835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric analysis of prefrontal cortex proteins in schizophrenia and bipolar disorder.
    Lakhan SE
    Springerplus; 2012; 1():3. PubMed ID: 23984221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder.
    Moreau MP; Bruse SE; David-Rus R; Buyske S; Brzustowicz LM
    Biol Psychiatry; 2011 Jan; 69(2):188-93. PubMed ID: 21183010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multilevel Functional Study of a
    Houenou J; Boisgontier J; Henrion A; d'Albis MA; Dumaine A; Linke J; Wessa M; Daban C; Hamdani N; Delavest M; Llorca PM; Lançon C; Schürhoff F; Szöke A; Le Corvoisier P; Barau C; Poupon C; Etain B; Leboyer M; Jamain S
    J Neurosci; 2017 Oct; 37(43):10389-10397. PubMed ID: 28972123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
    Miller CL; Llenos IC; Dulay JR; Weis S
    Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALDH4A1 expression levels are elevated in postmortem brains of patients with schizophrenia and are associated with genetic variants in enzymes related to proline metabolism.
    Nagaoka A; Kunii Y; Hino M; Izumi R; Nagashima C; Takeshima A; Sainouchi M; Nawa H; Kakita A; Yabe H
    J Psychiatr Res; 2020 Apr; 123():119-127. PubMed ID: 32065947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.
    Paterson C; Wang Y; Hyde TM; Weinberger DR; Kleinman JE; Law AJ
    Am J Psychiatry; 2017 Mar; 174(3):256-265. PubMed ID: 27771971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
    Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
    Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders.
    Hagihara H; Catts VS; Katayama Y; Shoji H; Takagi T; Huang FL; Nakao A; Mori Y; Huang KP; Ishii S; Graef IA; Nakayama KI; Shannon Weickert C; Miyakawa T
    Neuropsychopharmacology; 2018 Feb; 43(3):459-468. PubMed ID: 28776581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.